OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30

$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

OKYO Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

OKYO Pharma's enterprise value was $1.52B on May 31, 2023, against $1.37B a year earlier.

Period	Period end	Value	Change
2023	May 31, 2023	$1.52B	-18.4%
2022	Dec 30, 2022	$1.87B	–

See a number that looks wrong?